Related Experiment Video

Updated: Aug 18, 2026

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
07:13

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts

Published on: May 13, 2014

Long-term treatment of uraemic osteodystrophy with 1-alpha-hydroxycholecalciferol

S P Nielsen, E Binderup, W O Godtfredsen

    Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
    |January 1, 1976
    PubMed

    Insights

    1alpha-hydroxyvitamin D3 (1alphaOHD3) effectively treated hypocalcaemia and renal osteodystrophy in adolescent haemodialysis patients. Early intervention is key to preventing severe bone disease, with careful monitoring required to avoid hypercalcaemia.

    Area of Science:

    • Nephrology
    • Endocrinology
    • Pediatrics

    Background:

    • Adolescents undergoing regular haemodialysis often suffer from hypocalcaemia and renal osteodystrophy.
    • Uraemic osteodystrophy presents with elevated alkaline phosphatase and characteristic X-ray findings.
    • Clinical manifestations of bone disease can be present in these patients.

    Purpose of the Study:

    • To evaluate the efficacy of 1alpha-hydroxyvitamin D3 (1alphaOHD3) in treating bone disease in adolescent haemodialysis patients.
    • To assess the impact of 1alphaOHD3 on biochemical markers and radiological signs of uraemic osteodystrophy.

    Main Methods:

    • A cohort of three adolescent patients on regular haemodialysis received oral 1alphaOHD3 (0.25-10 mug/day) for over one year.
    • Patients were monitored for serum calcium, alkaline phosphatase levels, and X-ray changes indicative of bone disease.

    Main Results:

    • Treatment with 1alphaOHD3 led to normalization of serum calcium and alkaline phosphatase levels.
    • Significant improvement was observed in radiological signs of uraemic osteodystrophy.
    • Clinical improvement occurred, though to a lesser extent than biochemical and radiological markers.

    Conclusions:

    • 1alphaOHD3 is an effective treatment for hypocalcaemia and renal osteodystrophy in adolescent haemodialysis patients.
    • Initiating treatment before the onset of severe bone lesions is crucial for optimal outcomes.
    • Close monitoring during 1alphaOHD3 therapy is essential to prevent potential hypercalcaemia.

    More Related Videos

    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model08:53

    Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model

    Published on: January 1, 2017

    Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis09:51

    Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

    Published on: January 30, 2018

    Related Concept Videos

    Urinary Tract Calculi III: Medical Management01:30

    Urinary Tract Calculi III: Medical Management

    The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
    Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

    Urinary Tract Calculi IV: Nutrition Therapy and Prevention

    Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...